Conduit Pharmaceuticals (CDT) Financial Statements

Conduit Pharmaceuticals's market cap is currently $2.66M. The company's EPS TTM is $-21.276; its P/E ratio is >-0.01; Conduit Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.